Abstract
The development of polymer nanoparticles as drug carriers requires numerous steps including several in vitro evaluations in cell cultures and biocompatibility. To perform these experiments, it is crucial to express the particle concentration as the number of particles per volume unit or as the particle surface area. Calculation of these suspension characteristics can be perfomed knowing the size and the density of the nanoparticles as well as the polymer concentration. While particle size and polymer concentration are parameters being determined routinely, this study proposes to measure the density of the nanoparticle drug carriers by isopycnic centrifugation using linear sucrose gradients. The method was found to be very reproducible and it presents the advantage of being applied on a small sample of nanoparticles.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Chouinard F., S. Buczkowski & V. Lenaerts 1994. Polyalkylcyanoacrylate nanocapsules: Physicochemical characterization and mechanism of formation. Pharm. Res. 11, 869–874.
Colin deVerdière A., C. Dubernet, F. Nemati, E. Soma, M. Appel, J. Ferte, S. Bernard, F. Puisieux & P. Couvreur, 1997. Reversion of the multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action. British Journal of Cancer 76, 198–205.
Couvreur P., B. Kante, M. Roland, P. Guiot, P. Baudhuin & P. Speiser, 1979. Polyalkylcyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties. J. Pharm. Pharmacol. 31, 331–332.
Couvreur P. & C. Vauthier, 1994. Nanoparticles: therapeutic application and prospects. In: A.G. de Boer, ed. Drug Absorption Enhancement, Harwood Academic Publishers gmbh, Chur, Switzerland, pp. 457–486.
De Duve C., 1975. Exploring cells with a centrifuge. Science 189, 186–194.
Fattal E., C. Vauthier, I. Aynié, Y. Nakada, G. Lambert, C. Malvy & P. Couvreur, 1998. Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides. J. Controll. Rel. 53, 137–143.
Fessi H., F. Puisieux & J.P. Devissaguet, 1988. Process for the preparation of dispersible colloidal systems of a substance in the form of nanoparticles. US Patent No. 5,118,528.
Fritsch A., 1975. Les centrifugations préparatives en gradient de densité. 2nd Edition, Beckman Instruments France, Chap. 3, pp. 91–146.
Huve P., T. Verrecchia, D. Bazile, C. Vauthier & P. Couvreur, 1994. Simultaneous use of size-exclusion chromatography and photon correlation spectroscopy for the characterization of poly(lactic acid) nanoparticles. J. Chromatography A 675, 129–139.
Irache J., C. Durrer, G. Ponchel & D. Duchene, 1993. Determination of particle concentration in latexes by turbidimetry. Int. J. Pharm. 90, R9–R12.
Kattan J., J.P. Droz, P. Couvreur, J.P. Marino, A. Boutan-Laroze, P. Rougier, P. Brault, H. Vrancks, J.M. Grognet, X. Morge & H. Sancho-Garnier, 1992. Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles. Invest. New Drugs 10, 191–199.
Kreuter J., 1983. Physicochemical characterization of polyacrylic nanoparticles. Int. J. Pharm. 14, 43–58.
Mc Graw-Hill, 1992. Centrifugation. In: Encyclopedia of Sciences and Technology, Mc Graw-Hill Inc., New York, Saint-Louis, San Francisco, USA, Vol. 3, pp. 412–419.
Nemati F., C. Dubernet, A. Colin de Verdière, M.F. Poupon, L. Treupel-Acar, F. Puisieux & P. Couvreur, 1994. Cytotoxicity of free doxorubicin and doxoribicin-loaded nanoparticles in sensitive and multidrug resistant leucemic murine cells: incubation time, number of nanoparticles per cell. Int. J. of Pharm. 102, 55–62.
Rickwood D.,T. Ford & J. Steensgaard, 1994. Methods for preparing gradients. In Centrifugation Essential Data. JohnWiley and Sons, Inc., Huddersfield, UK, Chap. 8, pp. 56–64.
Rudd J.F., 1974. Physical constants of polystyrene. In: Polymer Handbook, 2nd Edition. Bandrup J. and Immergut E.H. eds. John Wiley and Sons Inc., New York, USA, p.V 59.
Schwab G., C. Chavany, I. Duroux, G. Goubin, J. Lebeau, C.Hélène & T.S. Behmoaras, 1994. Antisense oligonucleotides adsorbed to polyalkylcyanoacrylate nanoparticules specifically inhibit mutated Ha-ras-mediated cell proliferation and tumorigenicity in nude mice. Proc. Natl. Acad. Sci. USA 91, 10460–10464.
Vittaz M., D. Bazile, G. Spenlehauer, T. Verrecchia, M. Veillard, F. Puisieux & D. Labarre, 1996. Effect of PEO surface density on long-circulating PLA–POE nanoparticles which are very low complement activators. Biomaterials 17, 1575–1581.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vauthier, C., Schmidt, C. & Couvreur, P. Measurement of the Density of Polymeric Nanoparticulate Drug Carriers by Isopycnic Centrifugation. Journal of Nanoparticle Research 1, 411–418 (1999). https://doi.org/10.1023/A:1010031605547
Issue Date:
DOI: https://doi.org/10.1023/A:1010031605547